- Home
- FCUV vs FGEN Comparison
FCUV vs FGEN Comparison
Compare FCUV & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCUV
- FGEN
- Stock Information
- Founded
- FCUV 2012
- FGEN 1993
- Country
- FCUV United States
- FGEN United States
- Employees
- FCUV N/A
- FGEN N/A
- Industry
- FCUV Industrial Machinery/Components
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- FCUV Industrials
- FGEN Health Care
- Exchange
- FCUV Nasdaq
- FGEN Nasdaq
- Market Cap
- FCUV 27.6M
- FGEN 33.5M
- IPO Year
- FCUV N/A
- FGEN 2014
- Fundamental
- Price
- FCUV $3.19
- FGEN $8.07
- Analyst Decision
- FCUV
- FGEN Strong Buy
- Analyst Count
- FCUV 0
- FGEN 1
- Target Price
- FCUV N/A
- FGEN $250.00
- AVG Volume (30 Days)
- FCUV 17.0K
- FGEN 60.0K
- Earning Date
- FCUV 08-13-2025
- FGEN 08-05-2025
- Dividend Yield
- FCUV N/A
- FGEN N/A
- EPS Growth
- FCUV N/A
- FGEN N/A
- EPS
- FCUV N/A
- FGEN N/A
- Revenue
- FCUV $408,887.00
- FGEN $6,996,000.00
- Revenue This Year
- FCUV N/A
- FGEN N/A
- Revenue Next Year
- FCUV N/A
- FGEN N/A
- P/E Ratio
- FCUV N/A
- FGEN N/A
- Revenue Growth
- FCUV 6.49
- FGEN N/A
- 52 Week Low
- FCUV $1.50
- FGEN $4.50
- 52 Week High
- FCUV $10.90
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- FCUV 34.92
- FGEN 65.01
- Support Level
- FCUV $3.73
- FGEN $7.03
- Resistance Level
- FCUV $4.05
- FGEN $5.73
- Average True Range (ATR)
- FCUV 0.19
- FGEN 0.58
- MACD
- FCUV -0.03
- FGEN 0.33
- Stochastic Oscillator
- FCUV 5.97
- FGEN 94.43
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.